Volitionrx (VNRX) Operating Expenses (2011 - 2025)

Volitionrx's Operating Expenses history runs 11 years deep, the most recent figure standing at $5.3 million for Q4 2025.

• Quarterly Operating Expenses fell 11.85% year-over-year to $5.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $23.5 million (down 16.96% YoY) and the FY2025 annual result came in at $23.5 million, down 16.96% from the prior year.
• Operating Expenses was $5.3 million for Q4 2025 at Volitionrx, down from $5.7 million in the prior quarter.
• Across five years, Operating Expenses topped out at $9.8 million in Q2 2023 and bottomed at $5.3 million in Q4 2025.
• A 5-year average of $7.4 million and a median of $7.7 million in 2021 frame the typical range for Operating Expenses.
• Annual changes were most pronounced in 2021 — Operating Expenses soared 68.43% — and 2024, when it sank 33.52%.
• Volitionrx's Operating Expenses stood at $8.8 million in 2021, then slipped by 7.6% to $8.1 million in 2022, then climbed by 10.51% to $9.0 million in 2023, then sank by 33.52% to $6.0 million in 2024, then decreased by 11.85% to $5.3 million in 2025.
• Business Quant data shows VNRX's Operating Expenses at $5.3 million in Q4 2025, $5.7 million in Q3 2025, and $6.7 million in Q2 2025.